NYSE:IKT

Inhibikase Therapeutics News Headlines

$5.56

-0.06 (-1.07 %)

(As of 04/12/2021 12:00 AM ET)

Add

Today's Range

$5.42

Now: $5.56▼

$5.83

50-Day Range

$5.20

MA: $6.15▼

$7.83

52-Week Range

$5.12

Now: $5.56▼

$11.80

Volume15,986 shs

Average Volume102,391 shs

Market Capitalization$55.88 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Inhibikase Therapeutics (NYSE IKT) News Headlines Today

Source:

Source	Headline
	Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity finance.yahoo.com - April 1 at 12:00 PM
	Inhibikase Therapeutics (NYSE:IKT) Stock Price Up 5.3% americanbankingnews.com - April 1 at 12:44 AM
	Inhibikase Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Virtual Conference finance.yahoo.com - March 2 at 9:00 AM
	Inhibikase Therapeutics to Present at the American Society of Experimental Neurotherapeutics (ASENT) Conference finance.yahoo.com - February 22 at 9:40 AM
	Inhibikase Initiates Early-Stage Study Of Parkinson's Candidate finance.yahoo.com - February 17 at 6:32 PM
	Inhibikase Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial of IkT-148009 to Treat Parkinson’s Disease and Related Disorders finance.yahoo.com - February 17 at 8:31 AM
	Inhibikase Therapeutics Inc cnbc.com - January 27 at 6:20 PM
	Inhibikase Therapeutics Announces Partnership with Clintrex Research Corporation; C. Warren Olanow, MD, to Serve as Interim Chief Medical Officer finance.yahoo.com - January 4 at 8:44 AM
	2 More IPOs Make Their Trading Debuts Today barrons.com - December 24 at 11:08 PM
	Neurodegenerative disease biotech Inhibikase Therapeutics prices IPO at $10 low end nasdaq.com - December 24 at 11:08 PM
	Inhibikase, GBS Both Fall Below IPO Price in First Trading Day finance.yahoo.com - December 24 at 11:08 PM

This page was last updated on 4/12/2021 by MarketBeat.com Staff

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.